Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-09
2007-01-09
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S167000, C546S159000, C544S284000, C544S283000, C544S279000, C514S259500, C514S313000
Reexamination Certificate
active
10912185
ABSTRACT:
A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula [I]:in-line-formulae description="In-line Formulae" end="lead"?A-Het [I]in-line-formulae description="In-line Formulae" end="tail"?has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved.
REFERENCES:
patent: 3753988 (1973-08-01), Rodway et al.
patent: 6187781 (2001-02-01), Nakazato et al.
patent: 1 176 146 (2002-01-01), None
patent: 11-335373 (1999-12-01), None
patent: 11-335376 (1999-12-01), None
patent: 2000-86663 (2000-03-01), None
patent: WO 98/42699 (1998-10-01), None
patent: WO 98/47874 (1998-10-01), None
patent: WO 99/01454 (1999-01-01), None
patent: WO 00/53604 (2000-09-01), None
Kameo Kazuya
Kumagai Toshihito
Nakazato Atsuro
Okubu Taketoshi
Aulakh Charanjit S.
Sughrue & Mion, PLLC
Taisho Pharmaceutical Co. Ltd.
LandOfFree
Tetrahydropyridino or piperidino heterocyclic derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydropyridino or piperidino heterocyclic derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydropyridino or piperidino heterocyclic derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3764602